The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

HIK HIKMA PHARMACEUTICALS PLC ORD SHS 10P




 Page 1 of 3

| 1 | 2 | 3 | Next

Time/Date Code Headline Source Impact
16:09 17-May-2019 HIK Result of AGM RNS -2.48% Down
15:33 17-May-2019 HIK Director/PDMR Shareholding RNS -2.48% Down
07:00 17-May-2019 HIK Trading Statement RNS -2.48% Down
07:00 02-May-2019 HIK Total Voting Rights RNS +2.21% Up
09:00 01-May-2019 HIK Hikma launches 100th injectable medicine in US RNS +2.85% Up
16:26 15-Apr-2019 HIK Director/PDMR Shareholding RNS -4.21% Down
12:23 15-Apr-2019 HIK Annual Financial Report RNS -4.21% Down
17:42 01-Apr-2019 HIK Total Voting Rights RNS +3.31% Up
17:11 01-Apr-2019 HIK Block listing Interim Review RNS +3.31% Up
15:09 18-Mar-2019 HIK Director/PDMR Shareholding RNS +3.45% Up
10:32 15-Mar-2019 HIK Director/PDMR Shareholding RNS +0.96% Up
09:14 14-Mar-2019 HIK Director/PDMR Shareholding RNS -3.01% Down
13:50 13-Mar-2019 HIK Director/PDMR Shareholding RNS -5.46% Down
13:49 13-Mar-2019 HIK Director/PDMR Shareholding RNS -5.46% Down
07:00 13-Mar-2019 HIK Final Results RNS -5.46% Down
07:00 12-Mar-2019 HIK Directorate Change RNS -6.08% Down
16:51 01-Mar-2019 HIK Total Voting Rights RNS +1.52% Up
09:00 28-Feb-2019 HIK Hikma establishes partnership with Melinta in MENA RNS +1.64% Up
13:26 27-Feb-2019 HIK Block listing Interim Review RNS +0.24% Up
11:08 26-Feb-2019 HIK Notice of Results RNS -0.60% Down

 Page 1 of 3

| 1 | 2 | 3 | Next



Price changes are calculated on the basis of the following formula: [ avg(x) - avg(y)] / avg(y) where:
x = instrument's 7 closing prices after the news has been released
y = instrument's latest 7 closing prices before the news was released, including the day of the release of the news

Please note that the news releases are only one of the multiple factors that could have had an impact on the change in the security’s price over the time period analysed by the News Analysis tool. Where data are insufficient the graph does not show any price change and the table below the graph displays a blank “ - “ next to the line indicating the RNS issue.




Company Information
Company website http://www.hikma.com
Company address 1 New Burlington Place, London, W1S 2HR, United Kingdom
FTSE ICB sector Pharmaceuticals & Biotechnology
FTSE ICB subsector Pharmaceuticals
Company market cap, £m* 4,219.51
Admission date 04 Nov 2005
*The company market capitalization reflects the London listed element of Ordinary and Preference shares only and is approximate. Data provided by FTSE Russell.

Security Information
FTSE index FTSE 100,FTSE 350,FTSE 350 Low Yield,FTSE 350 (ex IT),FTSE All-Share,FTSE All-Share (ex IT),FTSE Euromid
Market Main Market
Market identifier code (MIC) XLON
Trading service SETS
Trading segment SET1
Listing category Premium Equity Commercial Companies
Country of share register GB
ISIN GB00B0LCW083
SEDOL B0LCW08
Exchange market size 1,000
Security market cap, £m 4,219.51
*The market capitalisation of the security reflects data from previous trading day.


HIKMA share news analysis (HIK)